10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and ...

This thesis explores how these memory T cells work in different viral infections, with a focus on Epstein-Barr virus (EBV), Human Immunodeficiency virus (HIV) and SARS-CoV-2 virus. First ...

(1 Trusted Source HIV weakens the immune system by attacking infection-fighting cells. While antiretroviral therapy controls the virus, it doesn’t cure it. Mount Sinai researchers ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a ...

Staying Golden: Aging With HIV: The Way Forward A longtime HIV/AIDS researcher and clinician maps out potential ways to approach a curative strategy, and comments on the need for global resources ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests. Allan from Maidenhead believes testing people for the virus when they visit A&E will help save lives.